Search Results 21-30 of 832 for ���������������������katalk:PC53���200%������ ��������� ������ ���������������������������������
... TP53 mutant acute myeloid leukemia (AML) who are appropriate for non-intensive therapy as measured by overall survival (OS). A Study of ASTX660 Alone or ...
The purpose of this study is to determine if axicabtagene ciloleucel is superior to standard of care (SOC) as measured by event-free survival (EFS), as ...
Learn how computer-assisted brain surgery uses advanced imaging to create a 3D model of your brain to help guide neurosurgery.
The purpose of this study is to evaluate the investigational drug PledOx in the prevention of chronic chemotherapy induced peripheral neuropathy (CIPN) induced ...
The purpose of this study is to compare Event-Free Survival (EFS) of participants in the primary analysis population with Stage II-IIIA RET fusion-positive Non- ...
TP-0903 has demonstrated profound single agent activity in CLL B cells taken directly from patients even if the patient has high risk factors (ie, 17p/P53 ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The P53/MDM2 pathway; The DNA damage response pathways in combination with radiation and chemotherapy; Signal transduction pathways. Defining the impact of the ...
About this study. The primary purpose of this study is to find out what effects (good or bad) the drugs auranofin and sirolimus have on patients with lung ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.